Ramaswamy reports 3.6% in Roivant Sciences (ROIV) on Schedule 13G/A

Rhea-AI Filing Summary

Roivant Sciences Ltd. ownership amendment: Vivek Ramaswamy reports beneficial ownership of 25,534,970 common shares, representing 3.6% of the outstanding common shares. The percentage is calculated using 715,701,137 shares outstanding as of February 2, 2026. The filing is an Amendment No. 7 to a Schedule 13G/A and is signed by an attorney-in-fact on behalf of Mr. Ramaswamy.

Key Figures

Beneficial ownership: 25,534,970 shares Percent of class: 3.6% Shares outstanding: 715,701,137 shares +2 more

5 metrics

Beneficial ownership 25,534,970 shares Amount beneficially owned reported on the Amendment

Percent of class 3.6% Percent of common shares outstanding as reported in Item 4

Shares outstanding 715,701,137 shares Aggregate common shares issued and outstanding as of February 2, 2026

Filing type Schedule 13G/A Amendment No. 7 Form type and amendment number stated on the cover

Signature date 05/06/2026 Date on the signed amendment

Key Terms

Schedule 13G/A, Beneficial ownership, CUSIP, Sole dispositive power

4 terms

Schedule 13G/A regulatory

"This Amendment No. 7 to a Schedule 13G/A is being filed"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership financial

"Amount beneficially owned: 25,534,970 common shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

CUSIP financial

"CUSIP No.: G76279101"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 25,534,970"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

Roivant Sciences Ltd.

(Name of Issuer)

Common Shares

(Title of Class of Securities)

G76279101

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G76279101

1

Names of Reporting Persons

Ramaswamy Vivek

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 25,534,970.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 25,534,970.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

25,534,970.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.6 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: All calculations of percentage ownership herein are based on an aggregate of 715,701,137 common shares issued and outstanding as of February 2, 2026, as disclosed by the Issuer in its Form 10-Q for the quarterly period ended December 31, 2025, as filed with the Securities and Exchange Commission on February 6, 2026. Ownership totals disclosed do not include 13,357,857 shares held solely by Mr. Ramaswamy's spouse.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Roivant Sciences Ltd.
(b)	Address of issuer's principal executive offices: 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM, SW1H 0DB.
Item 2.
(a)	Name of person filing: This Amendment to Schedule 13G {the "Amendment") is being filed by Vivek Ramaswamy (the "Reporting Person").
(b)	Address or principal business office or, if none, residence: c/o Steve Roberts, Lex Politica PLLC, 611 Pennsylvania Ave., SE, Ste 353, Washington, DC 20003
(c)	Citizenship: See row 4 of the cover page to this Amendment.
(d)	Title of class of securities: Common Shares
(e)	CUSIP No.: G76279101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 25,534,970 common shares
(b)	Percent of class: 3.6%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 25,534,970 common shares
	(ii) Shared power to vote or to direct the vote: N/A
	(iii) Sole power to dispose or to direct the disposition of: 25,534,970 common shares
	(iv) Shared power to dispose or to direct the disposition of: N/A
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Ramaswamy Vivek

Signature:	/s/ Stephen Roberts, as Attorney-in-Fact for Vivek Ramaswamy
Name/Title:	Vivek Ramaswamy
Date:	05/06/2026

FAQ

What stake does Vivek Ramaswamy report in ROIV?

Mr. Ramaswamy reports beneficial ownership of 25,534,970 common shares, equal to 3.6% of the class. This percentage is calculated using 715,701,137 shares outstanding as of February 2, 2026.

What form was filed to report this ROIV ownership?

The disclosure was filed as an Amendment No. 7 to a Schedule 13G/A. The filing updates previously reported beneficial ownership information and is signed by an attorney-in-fact for Mr. Ramaswamy.

Does the filing show shared voting or dispositive power for ROIV shares?

No. The filing states Mr. Ramaswamy has sole voting power and sole dispositive power over 25,534,970 shares, with 0 shares listed as shared power.

What baseline share count was used to compute the 3.6% in ROIV?

The percentage is based on an aggregate of 715,701,137 common shares issued and outstanding as of February 2, 2026, disclosed in the issuer's Form 10-Q for the period ended December 31, 2025.